Net profit of Bal Pharma rose 142.86% to Rs 3.57 crore in the quarter ended March 2019 as against Rs 1.47 crore during the previous quarter ended March 2018. Sales declined 2.97% to Rs 56.21 crore in the quarter ended March 2019 as against Rs 57.93 crore during the previous quarter ended March 2018.

For the full year,net profit rose 10.27% to Rs 6.55 crore in the year ended March 2019 as against Rs 5.94 crore during the previous year ended March 2018. Sales rose 6.30% to Rs 223.08 crore in the year ended March 2019 as against Rs 209.85 crore during the previous year ended March 2018.

Powered by Capital Market - Live News

Net profit of Bal Pharma rose 74.60% to Rs 1.10 crore in the quarter ended March 2019 as against Rs 0.63 crore during the previous quarter ended March 2018. Sales rose 0.46% to Rs 55.07 crore in the quarter ended March 2019 as against Rs 54.82 crore during the previous quarter ended March 2018.

For the full year,net profit rose 410.53% to Rs 1.94 crore in the year ended March 2019 as against Rs 0.38 crore during the previous year ended March 2018. Sales rose 6.40% to Rs 225.01 crore in the year ended March 2019 as against Rs 211.48 crore during the previous year ended March 2018.

Powered by Capital Market - Live News

Bal Pharma announced that the Board of Directors of the Company at its meeting held on 30 May 2019, inter alia, have recommended the final dividend of Rs 1 per equity Share (i.e. 10%) , subject to the approval of the shareholders.

Powered by Capital Market - Live News

Bal Pharma will hold a meeting of the Board of Directors of the Company on 29 May 2019.

Powered by Capital Market - Live News